Related Experiment Video
Updated: Jun 3, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Potential targets for pancreatic cancer immunotherapeutics
Lindzy F Dodson1, William G Hawkins, Peter Goedegebuure
1Washington University School of Medicine, Department of Surgery, Saint Louis, MO 63110, USA. lfriend@wustl.edu
Abstract:
Pancreatic adenocarcinoma is the fourth leading cause of cancer death with an overall 5-year survival of less than 5%. As there is ample evidence that pancreatic adenocarcinomas elicit antitumor immune responses, identification of pancreatic cancer-associated antigens has spurred the development of vaccination-based strategies for treatment. While promising results have been observed in animal tumor models, most clinical studies have found only limited success. As most trials were performed in patients with advanced pancreatic cancer, the contribution of immune suppressor mechanisms should be taken into account. In this article, we detail recent work in tumor antigen vaccination and the recently identified mechanisms of immune suppression in pancreatic cancer. We offer our perspective on how to increase the clinical efficacy of vaccines for pancreatic cancer.
Insights
Pancreatic cancer vaccines show promise in animal models but limited success in patients. Strategies to overcome immune suppression are crucial for improving pancreatic cancer treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Pancreatic adenocarcinoma is a deadly cancer with poor survival rates.
- Antigen identification has led to vaccine strategies for pancreatic cancer.
- Clinical trials show limited success, possibly due to immune suppression.
Purpose of the Study:
- To review recent advances in pancreatic cancer antigen vaccination.
- To discuss identified mechanisms of immune suppression in pancreatic cancer.
- To propose strategies for enhancing vaccine clinical efficacy.
Main Methods:
- Review of current literature on pancreatic cancer vaccines.
- Analysis of immune suppression mechanisms in pancreatic cancer.
- Synthesis of findings to propose future research directions.
Main Results:
- Promising results from animal tumor models for pancreatic cancer vaccines.
- Limited clinical success of current pancreatic cancer vaccine strategies.
- Emerging understanding of immune suppressive mechanisms hindering treatment.
Conclusions:
- Overcoming immune suppression is key to improving pancreatic cancer vaccine efficacy.
- Further research is needed to optimize vaccination strategies for pancreatic cancer patients.
- Targeting immune suppressive mechanisms may enhance antitumor responses.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

